VICTORY CAPITAL MANAGEMENT INC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,107,317
-25.0%
68,687
-2.1%
0.00%
-33.3%
Q2 2023$2,810,229
+1.6%
70,133
+3.5%
0.00%0.0%
Q1 2023$2,765,531
+10.9%
67,766
+4.9%
0.00%0.0%
Q4 2022$2,493,318
-36.7%
64,577
-12.8%
0.00%
-40.0%
Q3 2022$3,937,000
+3.5%
74,023
+13.5%
0.01%
+25.0%
Q2 2022$3,803,000
-29.5%
65,238
-8.5%
0.00%
-20.0%
Q1 2022$5,396,000
+20.1%
71,317
-4.5%
0.01%
+25.0%
Q4 2021$4,493,000
+11.8%
74,673
+4.0%
0.00%0.0%
Q3 2021$4,020,000
-3.8%
71,774
+4.2%
0.00%0.0%
Q2 2021$4,179,000
-29.1%
68,866
-18.1%
0.00%
-33.3%
Q1 2021$5,891,000
+482.1%
84,059
+396.8%
0.01%
+500.0%
Q4 2020$1,012,000
-5.5%
16,919
-5.0%
0.00%0.0%
Q3 2020$1,071,000
+60.3%
17,812
+40.0%
0.00%0.0%
Q2 2020$668,000
-16.3%
12,723
-46.6%
0.00%0.0%
Q1 2020$798,000
+49.2%
23,818
+101.5%
0.00%0.0%
Q4 2019$535,000
+58.8%
11,819
+33.6%
0.00%
Q3 2019$337,000
+1772.2%
8,845
+1584.8%
0.00%
Q2 2016$18,000
-33.3%
525
+4.4%
0.00%
Q1 2016$27,000
-25.0%
503
+7.9%
0.00%
Q4 2015$36,000
+350.0%
466
+141.5%
0.00%
Q3 2015$8,000
-33.3%
193
+10.3%
0.00%
Q2 2015$12,0001750.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders